Back to News
Market Impact: 0.2
New Study: City of Hope Blood Test Shows Promise for Detecting Pancreatic Cancer at Its Earliest Stages
Source: Business Wire
Healthcare & BiotechTechnology & Innovation
City of Hope researchers led development of an investigational blood test designed to detect pancreatic cancer at its earliest stages. The study signals potential progress in early cancer diagnosis, though no clinical-performance metrics, regulatory status, or commercialization timeline were provided.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
More News
- US official says upcoming spectrum auctions could generate more than $100 billion
- Investors react to Fed hike and market sell-off: Brace for 'higher for longer' rates
- AI Buildout Hits Inflation as Fed Hikes Rates
- OpenAI discloses six more instances of ’concerning’ AI model behavior
- The Competition's Response to Tesla Robotaxi Day
- Snap tries to bring AR glasses to enterprise market, partnering with Nvidia, AWS and Salesforce